+499.5%
MRNA vs BIIB
+55.8%
+443.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BIIB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.6% | -0.4% |
| 7D | +5.5% | +1.1% | +4.4% | +4.0% |
| 30D | +158.7% | +6.9% | +151.9% | +154.3% |
| 3M | +182.1% | +12.4% | +169.7% | +168.3% |
| 6M | +151.8% | +16.3% | +135.6% | +134.2% |
| YTD | +393.6% | +25.5% | +368.1% | +325.2% |
| 1Y | +499.5% | +57.8% | +441.7% | +330.7% |
| All | +499.5% | +55.8% | +443.7% | +330.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BIIB.
Daily Out/Under-Performance
Portfolio return minus BIIB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BIIB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BIIB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling